SCHEMBL27736226

SCHEMBL27736226

CC(C)(CCN1c2ccccc2OC1C=O)[N+](=O)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27756879 0.82 — —
SCHEMBL27608922 0.74 NPC1 (0.33) —
SCHEMBL7766488 0.73 HTT (0.35) —
SCHEMBL27590523 0.72 BCHE (0.30) —
SCHEMBL27590506 0.72 NPC1 (0.32) —
SCHEMBL27606465 0.71 P2RX4 (0.35) —
SCHEMBL28756718 0.70 ALDH1A1 (0.37) —
SCHEMBL27629689 0.70 MTNR1A (0.32) —
SCHEMBL27629478 0.69 HDAC3 (0.33) —
SCHEMBL27610601 0.69 PPARG (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101400675-A Novel enantiomerically pure beta-agonists, method for their production and their use as medicaments BOEHRINGER INGELHEIM INT (DE) 2009-04-01 — — CN disclosed
Send feedback